Ozempic Self-Pay Cost (No Insurance)
$349/month
Via NovoCare Pharmacy, 0.25mg–1mg doses. $499/month for 2mg.
If you've searched "how much is Ozempic without insurance," you've probably seen wildly different numbers — $199, $349, $1,000, even $1,400 for the same drug. That's not a typo or a scam. It reflects the fact that Ozempic has several completely separate price tags depending on how you pay for it.
Ozempic (semaglutide) is FDA-approved for type 2 diabetes, for reducing cardiovascular risk in adults with type 2 diabetes and heart disease, and for slowing chronic kidney disease progression in adults with type 2 diabetes and CKD. It's also widely used off-label for weight loss, though Novo Nordisk markets Wegovy specifically for that use.
This guide breaks down exactly what number applies to your situation: the manufacturer's list price, what retail pharmacies actually charge in cash, the NovoCare Pharmacy self-pay tiers, and what to do if even the lowest self-pay price is still out of reach.
Table of Contents
- Ozempic List Price vs. Real Cash Price
- Cash Price by Pharmacy: What to Expect
- NovoCare Pharmacy Self-Pay Program Explained
- The Ozempic Savings Card (Insured Patients Only)
- Eligibility Comparison: Savings Card vs. Self-Pay vs. PAP
- Income Limits for the Patient Assistance Program
- Covered Uses: What Counts as an FDA-Approved Indication
- Step-by-Step: How to Enroll in Self-Pay or the PAP
- Decision Tree: Which Payment Route Should You Use?
- Approval Timelines
- Renewing Your Enrollment
- Ozempic vs. Wegovy Pricing
- Pros and Cons of Each Payment Route
- Common Mistakes That Cost Patients Money
- Real Patient Scenarios
- Frequently Asked Questions
Ozempic List Price vs. Real Cash Price
The "list price" is the number Novo Nordisk publishes before any rebate, discount, or program is applied. As of mid-2026, that figure is $1,027.51 for a 28-day supply — one box containing one pen — and it's the same whether you're prescribed the 0.25mg starter dose or the 2mg maximum dose, according to Novo Nordisk's published list price explainer.
List price is not what pharmacies charge at the register, though. Retail cash prices — what you'd be quoted walking into a pharmacy with a prescription and no insurance or discount — commonly run higher than list price once pharmacy markup and dispensing fees are added, with some pricing trackers reporting cash quotes of $1,300 to $1,400 for a single pen.
| Price Type | Typical Amount | What It Means |
|---|---|---|
| Manufacturer list price | ~$1,027.51/month | Published price before any discount; same for every dose |
| Retail pharmacy cash price (no discount) | ~$1,300–$1,400/month | What an uninsured patient pays if no program is applied |
| NovoCare Pharmacy self-pay (standard) | $349–$499/month | Manufacturer's own cash-pay pharmacy, by dose tier |
| NovoCare Pharmacy self-pay (new patient intro) | $199/month | First two fills of 0.25mg or 0.5mg only |
| Ozempic Savings Card (commercially insured) | As low as $25/month | Requires insurance that covers Ozempic; max $100/month savings |
| Patient Assistance Program | $0/month | Income-eligible, uninsured patients only |
Why the confusion: Articles and forums often quote whichever number they happened to see — a retail cash price, the manufacturer's list price, or a self-pay tier — without saying which one applies to your situation. Match your insurance status to the right row in the table above before assuming any single price applies to you.
Cash Price by Pharmacy: What to Expect
Cash price for the same drug can vary from one pharmacy to the next, sometimes by 20% or more, because each pharmacy sets its own markup on top of wholesale acquisition cost. This is true whether you're comparing chain pharmacies or independents.
| Pharmacy Type | Approx. Cash Price (No Discount) | Notes |
|---|---|---|
| Large retail chains (CVS, Walgreens) | ~$1,000–$1,400 | Varies by location; always ask for the current cash price |
| Big-box / membership pharmacies (Costco, Walmart) | Often lower than chain drugstores | Some offer separate self-pay partnerships; membership may be required |
| NovoCare Pharmacy (manufacturer-run) | $199–$499 | Mail-order; bypasses retail markup entirely |
| Independent pharmacies | Highly variable | Worth calling ahead to compare against NovoCare pricing |
Before assuming a retail cash price is your only option, compare it against NovoCare Pharmacy's self-pay tiers using our Drug Price Checker. In nearly every case, NovoCare's self-pay program beats an unassisted retail cash price by a wide margin.
NovoCare Pharmacy Self-Pay Program Explained
NovoCare Pharmacy is Novo Nordisk's own direct-to-patient pharmacy. It's built specifically for people who are uninsured, or whose insurance doesn't cover Ozempic, and who want to pay cash without going through a retail pharmacy's markup.
| Patient Status | Dose | Monthly Price |
|---|---|---|
| New to Ozempic Savings Offer or NovoCare Pharmacy | 0.25mg or 0.5mg | $199 (first 2 fills only) |
| Existing self-pay patient | 0.25mg, 0.5mg, or 1mg | $349 |
| Existing self-pay patient | 2mg | $499 |
Important: The $199 introductory rate applies only to your first two monthly fills at the 0.25mg or 0.5mg starter doses. After that — or immediately if you're prescribed a higher dose — pricing moves to the standard $349 or $499 tier. Confirm current offer end dates directly at NovoCare's Ozempic pharmacy page before you enroll, since Novo Nordisk can modify or end the introductory offer at any time.
Self-pay through NovoCare means the prescription is processed entirely outside your insurance. It won't count toward your deductible or out-of-pocket maximum, so if you do have insurance that partially covers Ozempic, run the numbers both ways before choosing self-pay.
The Ozempic Savings Card (Insured Patients Only)
The Ozempic Savings Card is a separate program from NovoCare Pharmacy self-pay, and the two are frequently confused. The savings card is only for patients with commercial insurance that covers Ozempic for an FDA-approved use. It reduces your copay to as little as $25 for up to a 3-month supply, subject to a $100/month maximum savings.
| Feature | Ozempic Savings Card | NovoCare Self-Pay |
|---|---|---|
| Requires commercial insurance coverage of Ozempic | Yes | No — for uninsured or non-covered patients |
| Monthly cost | As low as $25 | $199–$499 |
| Applies toward deductible | Yes, through insurance | No — runs outside insurance entirely |
| Government beneficiaries eligible | No | No |
See our guide on manufacturer savings cards for how similar programs work across other brand-name medications, and our GoodRx vs. Inside Rx comparison if you want to check whether a third-party discount card might beat either Novo Nordisk program at your specific pharmacy.
Eligibility Comparison: Savings Card vs. Self-Pay vs. PAP
| Program | Insurance Required | Income Test | Government Beneficiaries |
|---|---|---|---|
| Ozempic Savings Card | Commercial insurance that covers Ozempic | None | Excluded |
| NovoCare Pharmacy Self-Pay | None — for uninsured or non-covered patients | None | Excluded |
| Patient Assistance Program (PAP) | Must be uninsured or underinsured | Yes — income limit applies | Case-by-case; most Part D enrollees now excluded since plans cover Ozempic |
Income Limits for the Patient Assistance Program
The Novo Nordisk Patient Assistance Program provides free medication to uninsured patients who meet income requirements, generally set around 200% of the Federal Poverty Level. For a single-person household that's roughly in the low-$30,000s annually; for a two-person household, roughly the high-$30,000s to low-$40,000s. These figures update each year, so confirm the current threshold before applying.
| Household Size | Approx. Income Limit (200% FPL, 2026) |
|---|---|
| 1 person | ~$30,000/year |
| 2 people | ~$41,000/year |
| 3 people | ~$51,000/year |
| 4 people | ~$62,000/year |
Our Patient Assistance Programs directory lists comparable income-based programs from other manufacturers. If your income is slightly above the PAP threshold, independent databases like NeedyMeds and BenefitsCheckUp can help you find state or nonprofit programs you might still qualify for.
Covered Uses: What Counts as an FDA-Approved Indication
Every Novo Nordisk savings program — the Savings Card, self-pay pricing, and the PAP — requires a prescription written for an FDA-approved use of Ozempic.
| Use | FDA-Approved for Ozempic? |
|---|---|
| Type 2 diabetes management | Yes |
| Reducing cardiovascular risk in T2D with heart disease | Yes |
| Slowing chronic kidney disease progression in T2D with CKD | Yes |
| Weight loss / chronic weight management (off-label for Ozempic) | Not the labeled use — see Wegovy instead |
Off-label weight loss note: Self-pay pricing through NovoCare Pharmacy typically doesn't check indication at checkout, but the Ozempic Savings Card does require an FDA-approved use to process through insurance. If your goal is weight management specifically, Wegovy — the same active ingredient, FDA-approved for chronic weight management — often has better insurance coverage and its own self-pay pricing.
Step-by-Step: How to Enroll in Self-Pay or the PAP
Confirm your insurance status
If you have commercial insurance that covers Ozempic, use the Ozempic Savings Card instead of self-pay. If you're uninsured or your plan excludes Ozempic, self-pay through NovoCare Pharmacy is usually your best option.
Get your prescription
You'll need a valid prescription for an FDA-approved use from a licensed prescriber. Telehealth prescriptions are accepted by NovoCare Pharmacy as long as they meet standard requirements.
Enroll at NovoCare Pharmacy
Visit novocare.com to set up a self-pay account, submit your prescription, and confirm your dose tier and monthly price before your first shipment.
If cost is still a barrier, apply to the PAP
Gather income documentation (recent tax return or pay stubs) and call 1-866-310-7549, or have your prescriber submit the PAP enrollment form on your behalf.
Compare against local pharmacy cash prices
Before committing, check a few retail pharmacies near you with our Drug Price Checker — occasionally a local cash price or coupon beats NovoCare's self-pay tier, especially for lower doses.
Decision Tree: Which Payment Route Should You Use?
Do you have commercial insurance that covers Ozempic?
Start here to route to the right program
Ozempic Savings Card
As low as $25/month, max $100/month savings
NovoCare Pharmacy Self-Pay
$199 intro, then $349–$499/month
Still can't afford it?
Apply to the Novo Nordisk Patient Assistance Program
Approval Timelines
| Program | Typical Timeline |
|---|---|
| Ozempic Savings Card (at pharmacy) | Immediate |
| NovoCare Pharmacy self-pay enrollment | Same day to a few business days for first shipment |
| Patient Assistance Program | Typically 2–4 weeks after a complete application |
| Prior authorization (if billing through insurance) | Usually 3–14 business days, longer if appealed |
If your insurer requires prior authorization before covering Ozempic, our Prior Authorization Guide walks through documentation that typically speeds up approval and how to appeal a denial.
Renewing Your Enrollment
- NovoCare Pharmacy self-pay pricing renews automatically each month as long as you keep filling; no separate reapplication is needed unless your dose changes.
- The $199 introductory rate is time-limited and tied to your first two fills — check the current offer window before assuming it will still apply at your next refill.
- The Patient Assistance Program typically requires reapplication or income re-verification, often annually — mark your enrollment date and follow up before it lapses.
- The Ozempic Savings Card terms are reviewed periodically by Novo Nordisk and can change; recheck eligibility if your insurance plan changes.
Ozempic vs. Wegovy Pricing
Ozempic and Wegovy share the same active ingredient, semaglutide, but have different FDA-approved indications and different self-pay pricing structures.
| Drug | FDA-Approved For | Self-Pay Starting Price |
|---|---|---|
| Ozempic (injection) | Type 2 diabetes, CV risk reduction, CKD progression | $199 intro, then $349–$499/month |
| Wegovy (injection) | Chronic weight management | $199 intro, then $349–$399/month |
If your goal is weight management and you don't have a type 2 diabetes diagnosis, ask your prescriber whether Wegovy is the more appropriate — and often better-covered — option.
Pros and Cons of Each Payment Route
| Payment Route | Pros | Cons |
|---|---|---|
| NovoCare Pharmacy Self-Pay | No income test; predictable flat pricing | Doesn't count toward insurance deductible; intro rate is temporary |
| Ozempic Savings Card | Lowest possible price if eligible; counts toward deductible | Requires commercial insurance that already covers the drug |
| Patient Assistance Program | Free medication if approved | Income limit; slower approval; annual reverification |
Common Mistakes That Cost Patients Money
- □ Paying an unassisted retail cash price without checking NovoCare Pharmacy's self-pay tiers first.
- □ Confusing the Ozempic Savings Card (insured only) with NovoCare self-pay (uninsured).
- □ Assuming the $199 introductory rate is permanent instead of a two-fill offer.
- □ Choosing self-pay when insurance would actually cost less after the deductible is factored in.
- □ Seeking out compounded semaglutide as a workaround — this is no longer a legal option following FDA enforcement action.
- □ Applying for the PAP without gathering income documentation first, which delays approval.
Real Patient Scenarios
Scenario 1 — Newly diagnosed, no insurance: A 41-year-old diagnosed with type 2 diabetes has no health insurance. She enrolls in NovoCare Pharmacy, starts on the 0.25mg dose at $199/month for her first two fills, then moves to $349/month as her dose is titrated up to 1mg.
Scenario 2 — Insured, but plan excludes GLP-1s: A patient's employer plan specifically excludes GLP-1 medications from coverage. Because insurance doesn't cover Ozempic, he isn't eligible for the Ozempic Savings Card and instead uses NovoCare self-pay at $349/month.
Scenario 3 — Insured and covered, high copay: A patient's plan covers Ozempic for type 2 diabetes but her copay is $120/month due to a high-tier formulary placement. She applies the Ozempic Savings Card, dropping her cost to $25/month.
Scenario 4 — Uninsured, very low income: A retiree not yet eligible for Medicare has no insurance and an annual income well under $30,000. Even $199/month is unmanageable, so he applies to the Patient Assistance Program and, once approved, receives Ozempic at no cost.
Bottom Line
The headline "$1,000+ a month" figure for Ozempic almost never has to be what you pay. Uninsured patients typically land between $199 and $499 a month through NovoCare Pharmacy, insured patients whose plan covers Ozempic can often get to $25 a month with the Savings Card, and income-eligible uninsured patients may pay nothing at all through the Patient Assistance Program.
If a pharmacy quotes you a price close to $1,000 or more, that's a sign to check NovoCare Pharmacy's self-pay pricing before you fill.
Frequently Asked Questions
The list price is about $1,027.51 for a 28-day supply regardless of dose, but almost no one pays that. Through NovoCare Pharmacy, uninsured patients typically pay $349 per month for the 0.25mg, 0.5mg, or 1mg doses, or $499 per month for the 2mg dose. New patients can start at $199 per month for their first two fills of the 0.25mg or 0.5mg dose.
That figure is the undiscounted retail cash price some pharmacies charge when a prescription is run with no insurance and no manufacturer program applied. It's higher than the manufacturer's own list price because it includes pharmacy markup and dispensing fees. Patients almost always do better going through NovoCare Pharmacy or a manufacturer savings offer instead of paying a retail pharmacy's unassisted cash price.
No. The $25/month Ozempic Savings Card requires commercial insurance that covers Ozempic for an FDA-approved use. Uninsured patients instead use the NovoCare Pharmacy self-pay program, which is separate and priced at $199 to $499 per month depending on dose and how long you've been enrolled.
It can be, through the Novo Nordisk Patient Assistance Program (PAP), for uninsured patients who meet income requirements, generally around 200% of the Federal Poverty Level. Patients must have a valid prescription for an FDA-approved use and apply with income documentation.
No. Federal law excludes beneficiaries of Medicare, Medicaid, TRICARE, and other government health programs from manufacturer copay cards and self-pay cash offers. Medicare Part D coverage rules, including expanded GLP-1 coverage for obesity starting mid-2026, apply instead. See our Medicare Part D coverage guide for details.
Widely available compounded semaglutide is no longer a legal option following FDA enforcement action that ended the shortage-based exemption that previously allowed compounding pharmacies to make copies of Ozempic and Wegovy.
The manufacturer's list price is the same for every dose strength. However, self-pay pricing through NovoCare Pharmacy is tiered: 0.25mg, 0.5mg, and 1mg doses cost $349/month, while the 2mg dose costs $499/month.
The introductory rate applies to your first two monthly fills of the 0.25mg or 0.5mg starter dose only. After that, standard self-pay pricing applies.
No. Self-pay pricing and third-party discount coupons are separate payment routes; a pharmacy will process one or the other, not both, on the same fill. Compare the prices ahead of time and choose whichever is lower.
Wegovy is the version of semaglutide FDA-approved specifically for chronic weight management, and it typically has better insurance coverage for that use than Ozempic, which is approved for type 2 diabetes and related conditions. Ask your prescriber which is appropriate for your diagnosis.
How We Researched This Guide
Sources
- NovoCare Pharmacy — Ozempic Self-Pay Pricing
- Novo Nordisk — Ozempic List Price Explainer
- Ozempic.com — Savings Card and Cost Information
- U.S. Food and Drug Administration — Drug Approvals and Databases
- Medicare.gov — Part D Prescription Drug Costs
- Centers for Medicare & Medicaid Services (CMS)
Related Savings Guides
- Wegovy Cost Without Insurance: 2026 Guide
- Novo Nordisk Patient Assistance Program
- GoodRx vs. Inside Rx: Which Saves More?
- Prior Authorization Guide for GLP-1 Medications
- Medicare Part D Insulin & GLP-1 Coverage
- Extra Help (LIS) for Medicare Part D
- Manufacturer Savings Cards: How They Work
- Patient Assistance Programs Directory
Editorial Policy: Refill Relay medical content is researched using manufacturer program terms, FDA prescribing information and pharmacist-reviewed pricing resources. Every article is reviewed for clarity, accuracy and usefulness before publication. Program eligibility, pricing and expiration dates are controlled by Novo Nordisk and subject to change without notice.